Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas
Glioblastoma multiforme (GBM) is the most incurable tumor (due to the difficulty in complete surgical resection and the resistance to conventional chemo/radiotherapies) that displays a high relapse frequency. Cancer stem cells (CSCs) have been considered as a promising target responsible for therapy...
Main Authors: | Yoshitaka Murota, Kouichi Tabu, Tetsuya Taga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/13/2054 |
Similar Items
-
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
by: Weilun Fu, et al.
Published: (2020-05-01) -
Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy
by: Sara Magri, et al.
Published: (2021-12-01) -
Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
by: Kshama Gupta, et al.
Published: (2018-11-01) -
Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
by: Aryeh Silver, et al.
Published: (2022-10-01) -
Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments
by: Tetsuya Taga, et al.
Published: (2020-09-01)